VRHI (Veri Medtech Holdings) EV-to-EBITDA: (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRHI Veri Medtech Holdings Inc VRHI
35 GF Score
Price $2.35
View Full Analysis

What is Veri Medtech Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Veri Medtech Holdings's enterprise value is $46.93 Mil. Veri Medtech Holdings does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2021. Therefore, GuruFocus does not calculate Veri Medtech Holdings's EV-to-EBITDA at this moment.

The historical rank and industry rank for Veri Medtech Holdings's EV-to-EBITDA or its related term are showing as below:

VRHI's EV-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.76
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2026-08-15), Veri Medtech Holdings's stock price is $2.3464. Veri Medtech Holdings does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021. Therefore, GuruFocus does not calculate Veri Medtech Holdings's PE Ratio (TTM) at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).

Veri Medtech Holdings  (OTCPK:VRHI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Veri Medtech Holdings's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.3464/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?

Veri Medtech Holdings EV-to-EBITDA Related Terms

Veri Medtech Holdings EV-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Veri Medtech Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veri Medtech Holdings EV-to-EBITDA Chart

Veri Medtech Holdings Annual Data
Trend Dec21
EV-to-EBITDA
0.00

Veri Medtech Holdings Semi-Annual Data
Dec21
EV-to-EBITDA 0.00

VRHI vs MMVVF, BLMZ, MVNC: EV-to-EBITDA Comparison

For the Health Information Services subindustry, Veri Medtech Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veri Medtech Holdings EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veri Medtech Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Veri Medtech Holdings's EV-to-EBITDA falls into.


VRHI
35GF Score
Veri Medtech Holdings Inc VRHI
EV-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veri Medtech Holdings EV-to-EBITDA Calculation

Veri Medtech Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=46.928/
=

Veri Medtech Holdings Business Description

Address 1660 International Drive, Suite 600, McClean, VA, USA, 22101
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score

Get the complete analysis for VRHI

EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price